share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

艾伯維公司 | 4：持股變動聲明-董事 Alpern Robert J
美股sec公告 ·  05/07 18:36
Moomoo AI 已提取核心訊息
On May 3, 2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Alpern's direct holdings in the company increased to a total of 34,443 shares. The grant, which is part of a standard company award or acquisition process, was completed on the same day. The shares acquired have a par value of $0.01 each, and the transaction was conducted in USD. This event could indicate the company's ongoing investment in its leadership team, potentially affecting investor sentiment.
On May 3, 2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Alpern's direct holdings in the company increased to a total of 34,443 shares. The grant, which is part of a standard company award or acquisition process, was completed on the same day. The shares acquired have a par value of $0.01 each, and the transaction was conducted in USD. This event could indicate the company's ongoing investment in its leadership team, potentially affecting investor sentiment.
2024年5月3日，與艾伯維公司 [ABBV] 關聯的羅伯特·阿爾珀恩免費獲得了1,322股普通股。在這筆交易之後，Alpern在該公司的直接持股量增加到總計34,443股。該補助金是標準公司獎勵或收購過程的一部分，已於當天完成。收購的股票每股面值爲0.01美元，交易以美元進行。該事件可能表明該公司正在對其領導團隊進行投資，這可能會影響投資者的情緒。
2024年5月3日，與艾伯維公司 [ABBV] 關聯的羅伯特·阿爾珀恩免費獲得了1,322股普通股。在這筆交易之後，Alpern在該公司的直接持股量增加到總計34,443股。該補助金是標準公司獎勵或收購過程的一部分，已於當天完成。收購的股票每股面值爲0.01美元，交易以美元進行。該事件可能表明該公司正在對其領導團隊進行投資，這可能會影響投資者的情緒。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息